array comparative genomic hybridization (acgh) 180k Search Results


oligonucleotide microarray 4 × 180k  (Agilent technologies)
95
Agilent technologies oligonucleotide microarray 4 × 180k
Oligonucleotide Microarray 4 × 180k, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/oligonucleotide microarray 4 × 180k/product/Agilent technologies
Average 95 stars, based on 1 article reviews
oligonucleotide microarray 4 × 180k - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
sureprint g3 human cgh microarray kit, 4×180k, amadid: 022060  (Agilent technologies)
90
Agilent technologies sureprint g3 human cgh microarray kit, 4×180k, amadid: 022060
Sureprint G3 Human Cgh Microarray Kit, 4×180k, Amadid: 022060, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sureprint g3 human cgh microarray kit, 4×180k, amadid: 022060/product/Agilent technologies
Average 90 stars, based on 1 article reviews
sureprint g3 human cgh microarray kit, 4×180k, amadid: 022060 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
180k comparative genomic hybridization array  (Agilent technologies)
90
Agilent technologies 180k comparative genomic hybridization array
180k Comparative Genomic Hybridization Array, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/180k comparative genomic hybridization array/product/Agilent technologies
Average 90 stars, based on 1 article reviews
180k comparative genomic hybridization array - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
180 k acgh/snp array  (Agilent technologies)
90
Agilent technologies 180 k acgh/snp array
<t>SNP</t> calling failure rate in association with DLR. SNP calling data were extracted from a . Agilent 180 K <t>aCGH/SNP</t> array, and b . Agilent 400 K aCGH/SNP array. SNP calling failure rate increased significantly when DLR is greater than 0.2 (**, p < 0.01). No significant difference (NS) between samples of DLR 0.2–0.3 and DLR > 0.3
180 K Acgh/Snp Array, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/180 k acgh/snp array/product/Agilent technologies
Average 90 stars, based on 1 article reviews
180 k acgh/snp array - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
sureprint g3 human cgh microarray kit  (Agilent technologies)
90
Agilent technologies sureprint g3 human cgh microarray kit
<t>SNP</t> calling failure rate in association with DLR. SNP calling data were extracted from a . Agilent 180 K <t>aCGH/SNP</t> array, and b . Agilent 400 K aCGH/SNP array. SNP calling failure rate increased significantly when DLR is greater than 0.2 (**, p < 0.01). No significant difference (NS) between samples of DLR 0.2–0.3 and DLR > 0.3
Sureprint G3 Human Cgh Microarray Kit, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sureprint g3 human cgh microarray kit/product/Agilent technologies
Average 90 stars, based on 1 article reviews
sureprint g3 human cgh microarray kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
superprint g3 4×180 k acgh microarrays  (Agilent technologies)
90
Agilent technologies superprint g3 4×180 k acgh microarrays
<t>SNP</t> calling failure rate in association with DLR. SNP calling data were extracted from a . Agilent 180 K <t>aCGH/SNP</t> array, and b . Agilent 400 K aCGH/SNP array. SNP calling failure rate increased significantly when DLR is greater than 0.2 (**, p < 0.01). No significant difference (NS) between samples of DLR 0.2–0.3 and DLR > 0.3
Superprint G3 4×180 K Acgh Microarrays, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/superprint g3 4×180 k acgh microarrays/product/Agilent technologies
Average 90 stars, based on 1 article reviews
superprint g3 4×180 k acgh microarrays - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
sureprint g3 human cgh microarray kit 4_180k  (Agilent technologies)
90
Agilent technologies sureprint g3 human cgh microarray kit 4_180k
<t>SNP</t> calling failure rate in association with DLR. SNP calling data were extracted from a . Agilent 180 K <t>aCGH/SNP</t> array, and b . Agilent 400 K aCGH/SNP array. SNP calling failure rate increased significantly when DLR is greater than 0.2 (**, p < 0.01). No significant difference (NS) between samples of DLR 0.2–0.3 and DLR > 0.3
Sureprint G3 Human Cgh Microarray Kit 4 180k, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sureprint g3 human cgh microarray kit 4_180k/product/Agilent technologies
Average 90 stars, based on 1 article reviews
sureprint g3 human cgh microarray kit 4_180k - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
sureprint g3 rat cgh 4 × 180k microarray, g4826a#27064  (Agilent technologies)
90
Agilent technologies sureprint g3 rat cgh 4 × 180k microarray, g4826a#27064
Expression <t>microarray</t> analysis at the subacute phase of Fe-NTA-induced renal carcinogenesis sorts out mitochondrial and iron metabolisms as candidate responsible pathways in Brca1 MUT(L63X/+) rat. (A) Results of hierarchical clustering and GO term analysis for the genes differentially expressed between WT and Brca1 MUT at 3 weeks in the Fe-NTA-induced renal carcinogenesis protocol (refer to ). (B) Renal Brca1 expression during the subacute phase of Fe-NTA-induced renal carcinogenesis protocol with qPCR (left panel; means ± SD) and immunoblot analysis (right panels). (C) Examples of altered metabolisms and mitochondrial dysfunction with expression microarray analysis specifically in the kidney of Brca1 MUT rats during the subacute phase of Fe-NTA-induced renal carcinogenesis (n = 3; * P < 0.05, ** P < 0.01, *** P < 0.001 vs wild-type Fe-NTA renal carcinogenesis protocol at 3 weeks). Refer to text for details.
Sureprint G3 Rat Cgh 4 × 180k Microarray, G4826a#27064, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sureprint g3 rat cgh 4 × 180k microarray, g4826a#27064/product/Agilent technologies
Average 90 stars, based on 1 article reviews
sureprint g3 rat cgh 4 × 180k microarray, g4826a#27064 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
sureprint g3 human cgh microarray  (Agilent technologies)
90
Agilent technologies sureprint g3 human cgh microarray
Expression <t>microarray</t> analysis at the subacute phase of Fe-NTA-induced renal carcinogenesis sorts out mitochondrial and iron metabolisms as candidate responsible pathways in Brca1 MUT(L63X/+) rat. (A) Results of hierarchical clustering and GO term analysis for the genes differentially expressed between WT and Brca1 MUT at 3 weeks in the Fe-NTA-induced renal carcinogenesis protocol (refer to ). (B) Renal Brca1 expression during the subacute phase of Fe-NTA-induced renal carcinogenesis protocol with qPCR (left panel; means ± SD) and immunoblot analysis (right panels). (C) Examples of altered metabolisms and mitochondrial dysfunction with expression microarray analysis specifically in the kidney of Brca1 MUT rats during the subacute phase of Fe-NTA-induced renal carcinogenesis (n = 3; * P < 0.05, ** P < 0.01, *** P < 0.001 vs wild-type Fe-NTA renal carcinogenesis protocol at 3 weeks). Refer to text for details.
Sureprint G3 Human Cgh Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sureprint g3 human cgh microarray/product/Agilent technologies
Average 90 stars, based on 1 article reviews
sureprint g3 human cgh microarray - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cytochip cancer 180k  (BlueGnome Limited)
90
BlueGnome Limited cytochip cancer 180k
Expression <t>microarray</t> analysis at the subacute phase of Fe-NTA-induced renal carcinogenesis sorts out mitochondrial and iron metabolisms as candidate responsible pathways in Brca1 MUT(L63X/+) rat. (A) Results of hierarchical clustering and GO term analysis for the genes differentially expressed between WT and Brca1 MUT at 3 weeks in the Fe-NTA-induced renal carcinogenesis protocol (refer to ). (B) Renal Brca1 expression during the subacute phase of Fe-NTA-induced renal carcinogenesis protocol with qPCR (left panel; means ± SD) and immunoblot analysis (right panels). (C) Examples of altered metabolisms and mitochondrial dysfunction with expression microarray analysis specifically in the kidney of Brca1 MUT rats during the subacute phase of Fe-NTA-induced renal carcinogenesis (n = 3; * P < 0.05, ** P < 0.01, *** P < 0.001 vs wild-type Fe-NTA renal carcinogenesis protocol at 3 weeks). Refer to text for details.
Cytochip Cancer 180k, supplied by BlueGnome Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cytochip cancer 180k/product/BlueGnome Limited
Average 90 stars, based on 1 article reviews
cytochip cancer 180k - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cytoscan hd  (Thermo Fisher)
90
Thermo Fisher cytoscan hd
Expression <t>microarray</t> analysis at the subacute phase of Fe-NTA-induced renal carcinogenesis sorts out mitochondrial and iron metabolisms as candidate responsible pathways in Brca1 MUT(L63X/+) rat. (A) Results of hierarchical clustering and GO term analysis for the genes differentially expressed between WT and Brca1 MUT at 3 weeks in the Fe-NTA-induced renal carcinogenesis protocol (refer to ). (B) Renal Brca1 expression during the subacute phase of Fe-NTA-induced renal carcinogenesis protocol with qPCR (left panel; means ± SD) and immunoblot analysis (right panels). (C) Examples of altered metabolisms and mitochondrial dysfunction with expression microarray analysis specifically in the kidney of Brca1 MUT rats during the subacute phase of Fe-NTA-induced renal carcinogenesis (n = 3; * P < 0.05, ** P < 0.01, *** P < 0.001 vs wild-type Fe-NTA renal carcinogenesis protocol at 3 weeks). Refer to text for details.
Cytoscan Hd, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cytoscan hd/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
cytoscan hd - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


SNP calling failure rate in association with DLR. SNP calling data were extracted from a . Agilent 180 K aCGH/SNP array, and b . Agilent 400 K aCGH/SNP array. SNP calling failure rate increased significantly when DLR is greater than 0.2 (**, p < 0.01). No significant difference (NS) between samples of DLR 0.2–0.3 and DLR > 0.3

Journal: Molecular Cytogenetics

Article Title: Analytical validation and chromosomal distribution of regions of homozygosity by oligonucleotide array comparative genomic hybridization from normal prenatal and postnatal case series

doi: 10.1186/s13039-019-0424-6

Figure Lengend Snippet: SNP calling failure rate in association with DLR. SNP calling data were extracted from a . Agilent 180 K aCGH/SNP array, and b . Agilent 400 K aCGH/SNP array. SNP calling failure rate increased significantly when DLR is greater than 0.2 (**, p < 0.01). No significant difference (NS) between samples of DLR 0.2–0.3 and DLR > 0.3

Article Snippet: SNP calling data were extracted from a . Agilent 180 K aCGH/SNP array, and b . Agilent 400 K aCGH/SNP array.

Techniques:

Expression microarray analysis at the subacute phase of Fe-NTA-induced renal carcinogenesis sorts out mitochondrial and iron metabolisms as candidate responsible pathways in Brca1 MUT(L63X/+) rat. (A) Results of hierarchical clustering and GO term analysis for the genes differentially expressed between WT and Brca1 MUT at 3 weeks in the Fe-NTA-induced renal carcinogenesis protocol (refer to ). (B) Renal Brca1 expression during the subacute phase of Fe-NTA-induced renal carcinogenesis protocol with qPCR (left panel; means ± SD) and immunoblot analysis (right panels). (C) Examples of altered metabolisms and mitochondrial dysfunction with expression microarray analysis specifically in the kidney of Brca1 MUT rats during the subacute phase of Fe-NTA-induced renal carcinogenesis (n = 3; * P < 0.05, ** P < 0.01, *** P < 0.001 vs wild-type Fe-NTA renal carcinogenesis protocol at 3 weeks). Refer to text for details.

Journal: Redox Biology

Article Title: BRCA1 haploinsufficiency promotes chromosomal amplification under Fenton reaction-based carcinogenesis through ferroptosis-resistance

doi: 10.1016/j.redox.2022.102356

Figure Lengend Snippet: Expression microarray analysis at the subacute phase of Fe-NTA-induced renal carcinogenesis sorts out mitochondrial and iron metabolisms as candidate responsible pathways in Brca1 MUT(L63X/+) rat. (A) Results of hierarchical clustering and GO term analysis for the genes differentially expressed between WT and Brca1 MUT at 3 weeks in the Fe-NTA-induced renal carcinogenesis protocol (refer to ). (B) Renal Brca1 expression during the subacute phase of Fe-NTA-induced renal carcinogenesis protocol with qPCR (left panel; means ± SD) and immunoblot analysis (right panels). (C) Examples of altered metabolisms and mitochondrial dysfunction with expression microarray analysis specifically in the kidney of Brca1 MUT rats during the subacute phase of Fe-NTA-induced renal carcinogenesis (n = 3; * P < 0.05, ** P < 0.01, *** P < 0.001 vs wild-type Fe-NTA renal carcinogenesis protocol at 3 weeks). Refer to text for details.

Article Snippet: We labeled DNA from 16 rat primary RCCs (4 in wild-type without metastasis, 4 in wild-type with pulmonary metastasis, 4 in Brca1-MUT rat without metastasis, and 4 in Brca1-MUT rat with pulmonary metastasis; randomly selected from RCC samples of appropriate size [diameter >15 mm] without massive necrosis and obtained by scheduled autopsy; ) with Cy-5 and the corresponding control DNA with Cy-3, which were applied to the aCGH microarray slides (SurePrint G3 Rat CGH 4 × 180k Microarray, G4826A#27064, Agilent Technologies, Santa Clara, CA) according to the Agilent Oligonucleotide Array-Based CGH for Genomic DNA Analysis protocol Ver.7.3.

Techniques: Expressing, Microarray, Western Blot